Endpoint Determination Study Protocol

NACompletedINTERVENTIONAL
Enrollment

556

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Irritable Bowel Syndrome
Interventions
OTHER

Food Elimination Diet

Subjects asked to participate in a food elimination diet, either True or Sham to evaluate the effects on their IBS symptoms

Trial Locations (8)

32224

Mayo Clinic, Jacksonville

60084

Family Medicine Specialists, Wauconda

77030

Houston Methodist Research Institute, Houston

UT Health, Houston

78229

Gastroenterology Research of San Antonio, San Antonio

85259

Mayo Clinic, Scottsdale

02215

Beth Israel Deaconess Medical Center, Boston

48109-5362

University of Michigan Health System, Ann Arbor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biomerica

INDUSTRY

NCT03459482 - Endpoint Determination Study Protocol | Biotech Hunter | Biotech Hunter